Who is the CEO of Biopol Chemicals Ltd?
- Answer Field
-
Santanu Sarkar, aged 60 years, is the Promoter and Managing Director of Biopol Chemicals. He has been associated with our Company since its inception.
Biopol Chemicals Limited is engaged in the manufacturing, trading, and distribution of specialty chemicals used across textiles, home care, agriculture, and industrial applications. Incorporated in 2023, the company operates with a business-to-business model and supplies its products mainly to institutional customers. Its portfolio includes a wide range of silicone-based products, emulsifiers, biochemicals, and polyelectrolytes, which are used in functional applications such as softening, cleaning, lubrication, and processing. The company operates manufacturing and support facilities in Gujarat and West Bengal, allowing it to serve customers across different regions through a combination of direct sales and distributor networks. Its market presence is linked to demand from downstream industries that use specialty chemicals as input materials in their production processes.
Investors who wish to apply for the Biopol Chemicals IPO can do so through the ASBA (Application Supported by Blocked Amount) facility using their bank account or through online trading platforms that support IPO applications. The process involves selecting the IPO, entering the number of lots to be applied for, and submitting the application after authorising the mandate for blocking funds. Once the IPO closes, a
llotment is finalised based on regulatory guidelines, and funds are debited only if shares are allotted. Applicants are advised to read the offer documents carefully before applying.
For more details, visit the Biopol Chemicals Limited IPO page.
Details | Information |
IPO Date | Feb 6, 2026 to Feb 10, 2026 |
Issue Size | 28,94,400 shares (agg. up to ₹31 Cr) |
Price Band | ₹102 to ₹108 per share |
Lot Size | 1200 shares |
Listing At | NSE SME |
Market Maker | Shreni Shares Ltd. |
Acquisition of industrial land
Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies.
General corporate purposes
Event | Date |
IPO Open Date | Fri, Feb 6, 2026 |
IPO Close Date | Tue, Feb 10, 2026 |
Tentative Allotment | Wed, Feb 11, 2026 |
Initiation of Refunds | Thu, Feb 12, 2026 |
Credit of Shares to Demat | Thu, Feb 12, 2026 |
Tentative Listing Date | Fri, Feb 13, 2026 |
Cut-off time for UPI mandate confirmation | 5 PM on Tue, Feb 10, 2026 |
₹102 to ₹108 per share
Application | Lots | Shares | Amount |
Individual investors (Retail) (Min) | 2 | 2,400 | ₹2,59,200 |
Individual investors (Retail) (Max) | 2 | 2,400 | ₹2,59,200 |
S-HNI (Min) | 3 | 3,600 | ₹3,88,800 |
S-HNI (Max) | 7 | 8,400 | ₹9,07,200 |
B-HNI (Min) | 8 | 9,600 | ₹10,36,800 |
The Biopol Chemicals Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Access your trading account using the broker's app or website.
Go to the IPO section to view active IPO listings.
Locate Biopol Chemicals Limited IPO in the list of available IPOs and click the ‘Apply’ button.
Specify the number of shares (lot size: 1200 shares) within the price band of ₹102 to ₹108 per share.
Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Submit the application and monitor the allotment status to check if shares have been allocated to you.
The allocation of shares in the Biopol Chemicals IPO is structured across investor categories in line with applicable regulatory requirements. The issue provides defined reservations for qualified institutional buyers, non-institutional investors, and retail individual investors, with each category allotted a specified proportion of the net issue. This allocation framework outlines how the shares offered are distributed among different classes of investors.
Investor Category | Shares Offered |
Market Maker Shares Offered | 1,51,200 (5.22%) |
QIB Shares Offered | 6,86,400 (23.71%) |
NII (HNI) Shares Offered | 10,94,400 (37.81%) |
− bNII > ₹10L | 7,29,600 (25.21%) |
− sNII < ₹10L | 3,64,800 (12.60%) |
Retail Shares Offered | 9,62,400 (33.25%) |
Total Shares Offered | 28,94,400 (100.00%) |
This reservation structure reflects the categorisation and allocation approach disclosed for the issue, indicating the proportion of shares available to each investor segment.
Total Assets: Grew from ₹17.56 crore in FY24 to ₹48.88 crore as of Dec 2025.
Total income: Reached ₹48.97 crore in Dec 2025, as compared to ₹17.43 crore in FY24.
Profit After Tax (PAT): Stood at ₹6.00 crore for Dec 2025 as compared to ₹2.96 crore in FY24.
Net Worth: Recorded at ₹19.54 crore in Dec 2025 in comparison to ₹9.20 crore in FY24.
Reserves and surplus: Stood at ₹11.63 crore in Dec 2025, as compared to ₹1.29 crore in FY24.
EBITDA: Stood at ₹8.99 crore in Dec 2025 in comparison to ₹4.43 crore in FY24.
The company reported an expansion in its asset base over the recent financial period, reflecting an increase in operational scale and balance sheet size.
Total income showed an upward trend, indicating higher business activity compared to the previous financial year.
Profitability levels improved during the period under review, supported by higher revenue generation from operations.
Net worth strengthened, primarily due to retained earnings and improved internal accruals.
Reserves and surplus increased, suggesting a gradual build-up of internal financial resources.
Operating performance improved, supported by steady business execution across product segments.
The company’s recent performance indicates a phase of operational expansion, while future growth would remain linked to market conditions, demand from end-user industries, and execution of business strategies.
The company operates primarily in a business-to-business model, which may result in revenue dependence on a limited set of institutional customers and exposure to changes in demand from end-user industries such as textiles, agriculture, and industrial manufacturing.
As a relatively young company with operations established in recent years, its business performance remains linked to execution capabilities, supply chain stability, regulatory compliance, and fluctuations in raw material availability.
Demand for specialty chemicals across textiles, home care, agriculture, and industrial applications may support business expansion, as these products are used as essential inputs in multiple manufacturing processes.
The proposed use of IPO proceeds for capacity-related expansion, land acquisition, and repayment of borrowings may support operational continuity and enable the company to scale its manufacturing and distribution activities over time.
KPI | Dec 31, 2025 | Mar 31, 2025 |
ROE | 36.32% | 38.10% |
ROCE | 26.32% | 30.57% |
Debt/Equity | 0.76 | 0.57 |
RoNW | 30.74% | 32.00% |
PAT Margin | 12.29% | 8.81% |
EBITDA Margin | 18.41% | 13.30% |
Price to Book Value | 4.37 | 6.31 |
Registrar | Lead Manager(s) |
Bigshare Services Pvt.Ltd. | Smart Horizon Capital Advisors Pvt.Ltd. |
Biopol Chemicals Ltd. D-211, 2nd Floor, Block-D, Sumel Business Park-6 Near Dudheshwar Circle Dudheshwar Tavdipura Ahmedabad, Gujarat, 380004
Phone: +91- 9147076778
Email: investors@biopolchemicals.com
Website: https://biopolchemicals.com/
Biopol Chemicals Limited operates in the specialty chemicals segment, with business activities focused on the manufacturing, trading, and distribution of products used across textiles, home care, agriculture, and industrial applications. The company follows a business-to-business model and serves institutional customers through direct sales and distributor networks. Its operations are supported by manufacturing and support facilities located in Gujarat and West Bengal. The IPO outlines defined objectives related to capital expenditure, debt repayment, working capital needs, and general corporate purposes, as disclosed in the offer details.
The application process for the IPO follows standard market procedures through online platforms using Demat and banking facilities. Investors may review the company’s business profile, disclosed financial information, risk factors, and issue structure as part of their assessment. Decisions related to participation in the issue may be considered in the context of individual financial goals and risk considerations.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Biopol Chemicals IPO allotment status.
No result found
Santanu Sarkar, aged 60 years, is the Promoter and Managing Director of Biopol Chemicals. He has been associated with our Company since its inception.
The public offer for the IPO is scheduled to open for subscription on February 6, 2026, and remain open until February 10, 2026, allowing prospective applicants to submit their bids within this time frame.
The company is engaged in the manufacturing, trading, and distribution of specialty chemical products used in textile processing, home care, agriculture, and industrial applications. It operates on a business-to-business model, supplying its products primarily to institutional customers through direct sales and distribution networks. Sustainability of the business model over time will be influenced by demand dynamics in downstream industries, cost structures, operational execution, and broader market conditions applicable to specialty chemical manufacturing.
The IPO comprises a total of 28,94,400 equity shares aggregating to approximately ₹31 crore. This issue size reflects the number of shares being offered to the public as disclosed in the offer documents.
A ‘pre-apply’ refers to the option available on some trading or investment platforms that allows prospective applicants to register their interest in an IPO before the subscription window opens. This feature is generally provided by brokers or platforms as a convenience for users to prepare for the application process once the IPO application period begins, and it does not alter the formal subscription dates set by the issuer.
The IPO is set with a lot size of 1,200 shares, and applicants must apply for a minimum of 2 lots.
According to disclosed timelines, the basis of allotment for the IPO is expected to be finalised on February 11, 2026, following the close of the subscription period.
Bigshare Services Private Limited is appointed as the registrar for the IPO, responsible for managing the share allotment process and related documentation for applicants.
There are no publicly stated governance issues or red flags highlighted. Investors may review the offer documents, including sections on management, board composition, and risk factors, for detailed and verified disclosures.
To apply for the IPO, a prospective applicant can use the ASBA (Application Supported by Blocked Amount) process through a bank account or through online trading platforms that support IPO applications. The process involves logging into the platform, selecting the IPO, entering the desired number of lots within the specified price band, providing a UPI ID for payment authorisation, and confirming the application before the cut-off time on the final day of subscription.
Yes, a Demat account is required to apply for the IPO, as shares allotted through the public offer are credited to the investor’s Demat account in electronic form, in accordance with regulatory norms governing electronic securities holdings.
After the allotment process is completed, the finalisation of the basis of allotment will be published on the registrar’s website and on relevant exchange portals. Applicants can check their status using their PAN, application number, or Demat account details on the registrar’s site or exchange allotment pages. Once shares are allotted, confirmation is reflected in the Demat account as per the timeline disclosed in the offer documents.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading